Clark Estates’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Clark Estates's CPRX Position: Q3 2026 in Review
Clark Estates sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 113,918 shares — an estimated $3.58M sold.
Clark Estates first reported a position in CPRX in Q3 2023 and held it in 12 quarters. The position peaked at $4.14M in Q3 2024. 2 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Clark Estates reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Clark Estates sold 113,918 Catalyst Pharmaceutical shares in Q3 2026, an estimated $3.58M.
- Clark Estates first reported a position in Catalyst Pharmaceutical in Q3 2023 and held it in 12 quarters.
- Clark Estates's Catalyst Pharmaceutical position peaked at $4.14M in Q3 2024.
- 2 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.